MedicaNatumin is a self-care group based in Habo and Jönköping, focusing on developing and marketing healthcare products based on innovative ingredients and solid research.

Our goal is to contribute to a positive health trend and to provide improved quality of life through products that treat or support the human body’s functions.

Among our product categories are dietary supplements, medical devices and dermatological and cosmetic products. Among the brands are leading dietary supplements like L-Argiplex and Nypozin and the scientifically documented skin care series Jabushe.

The foundation of MedicaNatumin’s business is to offer innovative products and strong brands from a sustainable and scientific base.
Our starting point is to have a strong position on the Nordic market while developing international partnerships and export operations.

We have all essential parts of the organisation; innovation and product development based on a strong patent platform, a local production that meets strict hygiene and quality requirements, a well-functioning sales and marketing department, and the entire organization is penetrated by clear roles and responsibilities.

Shares

Aktiestruktur

Antal aktier	375 289 277
Summa emitterat	375 289 277
Antal aktieägare	ca 1 914 st
Antal teckningsoptioner	17 000 000 (1 option = 1 aktie)
ISIN	Aktie SE0001789793

Statistik

Först	0.760
Högst	0.786
Medel	0.753
Lägst	0.732
Senast	0.758
+/- Sek	0.00
+/- %	0.00
Omsättning	162891.366
Volym	216055
ISIN	SE0001789793

Aktieägare

Aktieägare	Antal aktier	Andel (ca)
N.P.H i Habo AB	75 000 000	19,98%
Swedbank Försäkring AB	41 320 481	11,01%
Försäkringsbolaget, Avanza Pension	37 322 454	9,94%
Jool Invest AB	17 500 000	4,66%
TJ Gruppen AB	17 500 000	4,66%
Lars-Olof Johansson	8 683 360	2,31%
Jesper Pettersson	8 400 000	2,24%
Jörgen Wehmonen	6 872 660	1,83%
North Castle AB	6 153 933	1,64%
Karl-Olov Eriksson	6 119 725	1,63%
Summa	224 872 613	59,92%
Övriga 1 904 aktieägare	150 416 664	40,08%
Totalt antal aktier	375 289 277	100,00 %